ConductScience.org, home

Paper5936664

The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease.

Epstein SE and 1 other. Ann Intern Med, 1966. Cited by 129 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease. Papers, record 5936664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5936664

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease.
PubMed
Journal
Ann Intern Med
PubMed
Year
1966
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
129
iCite
Revised in PubMed
2019-06-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Epstein SES E
2Braunwald EE

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart DiseasesMajor topic
NatriuresisMajor topic
SympatholyticsMajor topic
Adult
Female
Humans
Male
Middle Aged
Propranolol

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
31,524,968GDMT for heart failure and the clinician's conundrum.Clin Cardiol2019https://conductscience.org/library/papers/31524968PubMed
30,062,151Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine.JACC Basic Transl Sci2017https://conductscience.org/library/papers/30062151PubMed
17,521,504Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure.Curr Heart Fail Rep2007https://conductscience.org/library/papers/17521504PubMed
12,381,236Optimising the use of beta-blockers in older patients with heart failure.Drugs Aging2002https://conductscience.org/library/papers/12381236PubMed
4,980,881New trends in the treatment of angina pectoris.Calif Med1969https://conductscience.org/library/papers/4980881PubMed
4,254,280Clinical evaluation of antiarrhythmic drugs.Naunyn Schmiedebergs Arch Pharmakol1971https://conductscience.org/library/papers/4254280PubMed
4,153,572Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.Drugs1974https://conductscience.org/library/papers/4153572PubMed
4,151,693Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.Drugs1974https://conductscience.org/library/papers/4151693PubMed
2,905,992Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/2905992PubMed
2,864,052Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2864052PubMed
2,864,051Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2864051PubMed
37,877beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.Br J Clin Pharmacol1979https://conductscience.org/library/papers/37877PubMed
37,873Diuretics as initial treatment for essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/37873PubMed
30,856[The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)].Klin Wochenschr1978https://conductscience.org/library/papers/30856PubMed
26,370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
17,766Side effects and contraindications of beta-receptor blocking agents.Klin Wochenschr1977https://conductscience.org/library/papers/17766PubMed
11,985Hypertension: which beta-blocker?Drugs1976https://conductscience.org/library/papers/11985PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5936664

GET https://conductscience.org/api/papers/v1/5936664/authors